CD163 and neoplasm: Interestingly, CD14−SIRPαlow cells exhibited properties of typical Mo/MΦs similar to CD14+SIRPαhi cells, but lacked CD163 expression, gained CD16 expression, migrated less and phagocytosed tumor cells less efficiently, yet stimulated rather than suppressed T-cell function.